{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:25:24Z","timestamp":1791923124879,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00336620"],"award-info":[{"award-number":["RS-2024-00336620"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02692-7","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:03:04Z","timestamp":1779062584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting EHMT2 overcomes 5-fluorouracil resistance in colorectal cancer by modulating cell cycle and apoptosis"],"prefix":"10.1038","volume":"11","author":[{"given":"In Hwan","family":"Tae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-gi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhyang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Young","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3795-4735","authenticated-orcid":false,"given":"Gyeonghwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taesang","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Rok","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwa","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1685-2887","authenticated-orcid":false,"given":"Moo-Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9280-5898","authenticated-orcid":false,"given":"Tae-Su","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-8812","authenticated-orcid":false,"given":"Mi-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8242-9390","authenticated-orcid":false,"given":"Hyun-Soo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2692_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah, H. et al. Colorectal cancer: recent advances in management and treatment. World J. Clin. Oncol. 15, 1136 (2024).","journal-title":"World J. Clin. Oncol."},{"key":"2692_CR2","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova, S. et al. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol. Ther. 206, 107447 (2020).","journal-title":"Pharmacol. Ther."},{"key":"2692_CR3","doi-asserted-by":"publisher","first-page":"658636","DOI":"10.3389\/fonc.2021.658636","volume":"11","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard, S. et al. 5-Fluorouracil: a narrative review on the role of regulatory mechanisms in driving resistance to this chemotherapeutic agent. Front. Oncol. 11, 658636 (2021).","journal-title":"Front. Oncol."},{"key":"2692_CR4","doi-asserted-by":"publisher","first-page":"115902","DOI":"10.1016\/j.bcp.2023.115902","volume":"218","author":"J Hu","year":"2023","unstructured":"Hu, J., Li, A., Guo, Y., Ma, T. & Feng, S. The relationship between tumor metabolism and 5-fluorouracil resistance. Biochem. Pharmacol. 218, 115902 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"2692_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0128-8","volume":"50","author":"L He","year":"2018","unstructured":"He, L. et al. Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells. Exp. Mol. Med. 50, 1\u201312 (2018).","journal-title":"Exp. Mol. Med."},{"key":"2692_CR6","doi-asserted-by":"publisher","first-page":"111285","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy, C. & Kundu, C. N. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition. Biomed. Pharmacother. 137, 111285 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"2692_CR7","doi-asserted-by":"publisher","first-page":"117576","DOI":"10.1016\/j.biopha.2024.117576","volume":"180","author":"M Shao","year":"2024","unstructured":"Shao, M. et al. Expediting the development of robust 5-FU-resistant colorectal cancer models using innovative combined in vivo and in vitro strategies. Biomed. Pharmacother. 180, 117576 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"2692_CR8","doi-asserted-by":"crossref","unstructured":"Ashique, S. et al. Multi drug resistance in colorectal cancer-approaches to overcome, advancements and future success. Adv. Cancer Biol. Metastasis 10, 100114 (2024).","DOI":"10.1016\/j.adcanc.2024.100114"},{"key":"2692_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","volume":"17","author":"G Jung","year":"2020","unstructured":"Jung, G., Hern\u00e1ndez-Ill\u00e1n, E., Moreira, L., Balaguer, F. & Goel, A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat. Rev. Gastroenterol. Hepatol. 17, 111\u2013130 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2692_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov. 10, 28 (2024).","journal-title":"Cell Death Discov."},{"key":"2692_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1085391","volume":"13","author":"L Ren","year":"2023","unstructured":"Ren, L. et al. Recent advances in epigenetic anticancer therapeutics and future perspectives. Front. Genet. 13, 1085391 (2023).","journal-title":"Front. Genet."},{"key":"2692_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai, W. et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct. Target. Ther. 9, 332 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2692_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01682-z","volume":"39","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. Histone methyltransferase and drug resistance in cancers. J. Exp. Clin. Cancer Res. 39, 1\u201313 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2692_CR14","doi-asserted-by":"publisher","first-page":"1376916","DOI":"10.3389\/fonc.2024.1376916","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer. Front. Oncol. 14, 1376916 (2024).","journal-title":"Front. Oncol."},{"key":"2692_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jhep.2017.05.015","volume":"67","author":"L Wei","year":"2017","unstructured":"Wei, L. et al. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J. Hepatol. 67, 758\u2013769 (2017).","journal-title":"J. Hepatol."},{"key":"2692_CR16","doi-asserted-by":"crossref","unstructured":"Zhou, H., Gui, J., Zhu, L. & Mi, Y. The role and mechanism of the histone methyltransferase G9a in tumors: update. Onco Targets Ther. 17, 449\u2013462 (2024).","DOI":"10.2147\/OTT.S451108"},{"key":"2692_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41396-021-01119-1","volume":"16","author":"TY Ryu","year":"2022","unstructured":"Ryu, T. Y. et al. Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer. ISME J. 16, 1205\u20131221 (2022).","journal-title":"ISME J."},{"key":"2692_CR18","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/nar\/gky1230","volume":"47","author":"Y-C Chae","year":"2019","unstructured":"Chae, Y.-C. et al. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Nucleic Acids Res. 47, 1692\u20131705 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2692_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/15384101.2020.1719585","volume":"19","author":"ML Schmitz","year":"2020","unstructured":"Schmitz, M. L., Higgins, J. M. & Seibert, M. Priming chromatin for segregation: functional roles of mitotic histone modifications. Cell Cycle 19, 625\u2013641 (2020).","journal-title":"Cell Cycle"},{"key":"2692_CR20","doi-asserted-by":"publisher","first-page":"173827","DOI":"10.1016\/j.ejphar.2020.173827","volume":"893","author":"S Jan","year":"2021","unstructured":"Jan, S. et al. Targeting EHMT2\/G9a for cancer therapy: progress and perspective. Eur. J. Pharmacol. 893, 173827 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"2692_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40164-024-00554-y","volume":"13","author":"TY Ryu","year":"2024","unstructured":"Ryu, T. Y. et al. Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer. Exp. Hematol. Oncol. 13, 86 (2024).","journal-title":"Exp. Hematol. Oncol."},{"key":"2692_CR22","first-page":"2168","volume":"7","author":"MA Shah","year":"2001","unstructured":"Shah, M. A. & Schwartz, G. K. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin. Cancer Res. 7, 2168\u20132181 (2001).","journal-title":"Clin. Cancer Res."},{"key":"2692_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tips.2017.02.001","volume":"38","author":"R Nussinov","year":"2017","unstructured":"Nussinov, R., Tsai, C.-J. & Jang, H. A new view of pathway-driven drug resistance in tumor proliferation. Trends Pharmacol. Sci. 38, 427\u2013437 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"2692_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89519-7","volume":"15","author":"G-w Zhu","year":"2025","unstructured":"Zhu, G. -w et al. PPM1B degradation mediated by TRIM25 ubiquitination modulates cell cycle and promotes gastric cancer growth. Sci. Rep. 15, 6160 (2025).","journal-title":"Sci. Rep."},{"key":"2692_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cbin.12092","volume":"48","author":"Y Yu","year":"2024","unstructured":"Yu, Y., Liu, Q., Ran, Q. & Cao, F. Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells. Cell Biol. Int. 48, 143\u2013153 (2024).","journal-title":"Cell Biol. Int."},{"key":"2692_CR26","first-page":"263","volume":"2","author":"E Wang","year":"2022","unstructured":"Wang, E., Xiang, K., Zhang, Y. & Wang, X.-F. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): new opportunities in establishing faithful pre-clinical cancer models. J. Natl. Cancer Cent. 2, 263\u2013276 (2022).","journal-title":"J. Natl. Cancer Cent."},{"key":"2692_CR27","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1038\/s41388-021-02029-4","volume":"40","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin \u03b23\/SRC pathway. Oncogene 40, 6369\u20136380 (2021).","journal-title":"Oncogene"},{"key":"2692_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff, Y. R., Warner, A. B. & Wolchok, J. D. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res. 30, 507\u2013519 (2020).","journal-title":"Cell Res."},{"key":"2692_CR29","doi-asserted-by":"publisher","first-page":"216396","DOI":"10.1016\/j.canlet.2023.216396","volume":"575","author":"Z Luo","year":"2023","unstructured":"Luo, Z., Eichinger, K. M., Zhang, A. & Li, S. Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy. Cancer Lett. 575, 216396 (2023).","journal-title":"Cancer Lett."},{"key":"2692_CR30","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.3390\/cancers16132478","volume":"16","author":"P Garg","year":"2024","unstructured":"Garg, P. et al. Emerging therapeutic strategies to overcome drug resistance in cancer cells. Cancers 16, 2478 (2024).","journal-title":"Cancers"},{"key":"2692_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/138161282005140214165212","volume":"20","author":"Y Hee Choi","year":"2014","unstructured":"Hee Choi, Y. & Yu, A.-M. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr. Pharm. Des. 20, 793\u2013807 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"2692_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2023.5567","volume":"63","author":"Y Tian","year":"2023","unstructured":"Tian, Y. et al. Mechanism of multidrug resistance to chemotherapy mediated by P\u2011glycoprotein. Int. J. Oncol. 63, 1\u201319 (2023).","journal-title":"Int. J. Oncol."},{"key":"2692_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.265","volume":"4","author":"ZN Lei","year":"2023","unstructured":"Lei, Z. N. et al. Understanding and targeting resistance mechanisms in cancer. MedComm 4, e265 (2023).","journal-title":"MedComm"},{"key":"2692_CR34","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","volume":"22","author":"DM Townsend","year":"2003","unstructured":"Townsend, D. M. & Tew, K. D. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22, 7369\u20137375 (2003).","journal-title":"Oncogene"},{"key":"2692_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/antiox10050701","volume":"10","author":"RR Singh","year":"2021","unstructured":"Singh, R. R. & Reindl, K. M. Glutathione S-transferases in cancer. Antioxidants 10, 701 (2021).","journal-title":"Antioxidants"},{"key":"2692_CR36","doi-asserted-by":"publisher","first-page":"702642","DOI":"10.3389\/fonc.2021.702642","volume":"11","author":"M Gaggianesi","year":"2021","unstructured":"Gaggianesi, M. et al. Messing up the cancer stem cell chemoresistance mechanisms supported by tumor microenvironment. Front. Oncol. 11, 702642 (2021).","journal-title":"Front. Oncol."},{"key":"2692_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu, X. et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct. Target. Ther. 9, 170 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2692_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/cells8040350","volume":"8","author":"M Nadeem Abbas","year":"2019","unstructured":"Nadeem Abbas, M., Kausar, S., Wang, F., Zhao, Y. & Cui, H. Advances in targeting the epidermal growth factor receptor pathway by synthetic products and its regulation by epigenetic modulators as a therapy for glioblastoma. Cells 8, 350 (2019).","journal-title":"Cells"},{"key":"2692_CR39","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","volume":"54","author":"H-Y Min","year":"2022","unstructured":"Min, H.-Y. & Lee, H.-Y. Molecular targeted therapy for anticancer treatment. Exp. Mol. Med. 54, 1670\u20131694 (2022).","journal-title":"Exp. Mol. Med."},{"key":"2692_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang, N., Ma, T. & Yu, B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal. Transduct. Target. Ther. 8, 69 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"2692_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore, L. D., Le, T. & Fan, G. DNA methylation and its basic function. Neuropsychopharmacology 38, 23\u201338 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"2692_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41580-022-00483-w","volume":"23","author":"J Padeken","year":"2022","unstructured":"Padeken, J., Methot, S. P. & Gasser, S. M. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. Nat. Rev. Mol. Cell Biol. 23, 623\u2013640 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2692_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1152\/physiol.00034.2011","volume":"27","author":"H Sun","year":"2012","unstructured":"Sun, H. & Wang, Y. Novel Ser\/Thr protein phosphatases in cell death regulation. Physiology 27, 43\u201352 (2012).","journal-title":"Physiology"},{"key":"2692_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07269-2","volume":"15","author":"L Lagorgette","year":"2024","unstructured":"Lagorgette, L., Bogdanova, D. A., Belotserkovskaya, E. V., Garrido, C. & Demidov, O. N. PP2C phosphatases\u2014terminators of suicidal thoughts. Cell Death Dis. 15, 919 (2024).","journal-title":"Cell Death Dis."},{"key":"2692_CR45","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/febs.16334","volume":"289","author":"A Nachiyappan","year":"2022","unstructured":"Nachiyappan, A., Gupta, N. & Taneja, R. EHMT1\/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms. FEBS J. 289, 1329\u20131351 (2022).","journal-title":"FEBS J."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02692-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:03:06Z","timestamp":1779062586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02692-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02692-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}